Profile data is unavailable for this security.
About the company
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
- Revenue in USD (TTM)8.34m
- Net income in USD-10.92m
- Incorporated2008
- Employees31.00
- LocationReShape Lifesciences Inc1001 CALLE AMANECERSAN CLEMENTE 92673United StatesUSA
- Phone+1 (949) 429-6680
- Fax+1 (302) 636-5454
- Websitehttps://www.reshapelifesciences.com/obalon/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioelectronics Corp | 1.61m | -289.82k | 4.94m | 9.00 | -- | -- | -- | 3.07 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
Pressure Biosciences Inc | 2.27m | -29.56m | 5.00m | 15.00 | -- | -- | -- | 2.20 | -1.70 | -1.70 | 0.1299 | -1.22 | 1.02 | 2.28 | 9.17 | 151,505.30 | -1,074.63 | -643.54 | -- | -- | 6.89 | 34.75 | -1,050.30 | -798.21 | 0.0185 | -0.4182 | -- | -- | -13.64 | -5.05 | 21.52 | -- | -34.47 | -- |
Arch Therapeutics Inc | 130.55k | -8.43m | 5.02m | 8.00 | -- | -- | -- | 38.47 | -3.68 | -3.68 | 0.0425 | -2.45 | 0.0833 | 0.0637 | -- | 16,318.75 | -538.25 | -188.28 | -- | -804.63 | 33.37 | -- | -6,458.14 | -26,945.92 | 0.0164 | -1.27 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
Hawkeye Systems Inc | 0.00 | -804.18k | 5.11m | 44.00 | -- | -- | -- | -- | -0.1186 | -0.1186 | 0.00 | -0.29 | 0.00 | -- | -- | -- | -66.07 | -330.11 | -- | -- | -- | -- | -- | -218.49 | -- | -2.78 | 10.45 | -- | -- | -- | 4.85 | -- | -- | -- |
Nexalin Technology Inc | 158.86k | -4.94m | 5.21m | 6.00 | -- | 2.24 | -- | 32.77 | -0.6676 | -0.6676 | 0.0215 | 0.3129 | 0.0363 | 0.1778 | 44.01 | 26,476.67 | -112.76 | -- | -139.94 | -- | 82.54 | -- | -3,110.58 | -- | 4.75 | -- | 0.00 | -- | -91.62 | -- | -173.80 | -- | -- | -- |
ADM Tronics Unlimited Inc | 2.85m | -716.86k | 5.34m | 7.00 | -- | 4.84 | -- | 1.88 | -0.0106 | -0.0106 | 0.0421 | 0.0163 | 0.9772 | 3.85 | 4.25 | -- | -24.62 | -11.45 | -38.81 | -15.77 | 38.45 | 43.73 | -25.19 | -15.28 | 1.24 | -- | 0.2902 | -- | 14.66 | -0.4159 | 93.04 | -- | -- | -- |
Guided Therapeutics Inc | 82.00k | -3.23m | 5.57m | 4.00 | -- | -- | -- | 67.91 | -0.0623 | -0.0623 | 0.0016 | -0.0721 | 0.0374 | 0.0904 | 11.71 | 20,500.00 | -137.80 | -136.13 | -- | -- | 32.93 | 29.39 | -3,685.37 | -3,666.67 | 0.1138 | -11.13 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
BIOLASE Inc | 48.83m | -38.26m | 5.70m | 157.00 | -- | -- | -- | 0.1168 | -20.50 | -20.50 | 8.64 | 0.0081 | 1.28 | 2.21 | 9.00 | 311,006.40 | -55.75 | -49.28 | -118.58 | -85.80 | 34.25 | 35.27 | -43.56 | -50.72 | 0.6409 | -5.98 | 0.9812 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
Predictive Oncology Inc | 1.96m | -14.78m | 5.87m | 34.00 | -- | 1.43 | -- | 2.99 | -3.66 | -3.66 | 0.4853 | 0.9977 | 0.1099 | 1.71 | 4.95 | 57,642.65 | -82.89 | -91.80 | -108.54 | -126.29 | 64.18 | 64.64 | -754.19 | -1,419.99 | 1.35 | -- | 0.0093 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
Encision Inc | 6.87m | -448.00k | 5.88m | 31.00 | -- | 2.68 | -- | 0.857 | -0.0381 | -0.0381 | 0.5835 | 0.1863 | 1.64 | 1.96 | 7.84 | 221,520.00 | -10.69 | -1.07 | -14.05 | -1.46 | 50.54 | 52.27 | -6.52 | -0.613 | 1.08 | -6.22 | 0.1123 | -- | -4.17 | -3.44 | -393.90 | -- | 12.89 | -- |
ReShape Lifesciences Inc | 8.34m | -10.92m | 5.98m | 31.00 | -- | 1.32 | -- | 0.7174 | -2.30 | -2.30 | 0.7319 | 0.1933 | 0.6781 | 0.8178 | 4.52 | 268,871.00 | -88.83 | -136.06 | -162.20 | -194.32 | 65.85 | 56.30 | -130.99 | -408.36 | 1.26 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
Sharps Technology Inc | 0.00 | -8.71m | 5.99m | 3.00 | -- | 0.8726 | -- | -- | -0.6204 | -0.6204 | 0.00 | 0.4378 | 0.00 | -- | -- | -- | -74.67 | -- | -95.84 | -- | -- | -- | -- | -- | 0.492 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
Sonendo Inc | 40.19m | -57.74m | 6.05m | 216.00 | -- | 0.2464 | -- | 0.1504 | -0.6125 | -0.5552 | 0.426 | 0.3482 | 0.4448 | 2.07 | 7.58 | 186,055.60 | -63.91 | -- | -78.82 | -- | 27.64 | -- | -143.67 | -- | 2.14 | -10.83 | 0.4695 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
Fuse Medical Inc | 18.40m | 3.63m | 6.06m | 31.00 | 2.28 | -- | 1.64 | 0.3295 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
Sigyn Therapeutics Inc | 0.00 | -3.56m | 6.43m | 5.00 | -- | -- | -- | -- | -3.04 | -3.04 | 0.00 | -3.28 | 0.00 | -- | -- | 0.00 | -724.37 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0199 | -1.92 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
Vivos Therapeutics Inc | 13.36m | -15.64m | 6.74m | 114.00 | -- | 9.81 | -- | 0.5048 | -11.00 | -11.00 | 8.73 | 0.2131 | 0.9247 | -- | 31.59 | 117,219.30 | -108.24 | -89.72 | -243.30 | -149.70 | 58.90 | 70.20 | -117.06 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Mar 2024 | 49.87k | 0.21% |
Tower Research Capital LLCas of 31 Mar 2024 | 49.57k | 0.21% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 34.06k | 0.15% |
Millennium Management LLCas of 31 Mar 2024 | 29.79k | 0.13% |
Gesalcal� SA SGIICas of 31 Dec 2023 | 26.01k | 0.11% |
Goldman Sachs & Co. LLC (Private Banking)as of 31 Mar 2024 | 23.04k | 0.10% |
Jane Street Capital LLCas of 31 Mar 2024 | 22.93k | 0.10% |
Geode Capital Management LLCas of 31 Mar 2024 | 18.35k | 0.08% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 13.02k | 0.06% |
Two Sigma Securities LLCas of 31 Mar 2024 | 12.82k | 0.06% |